InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: geocappy1 post# 203915

Sunday, 01/25/2015 5:02:44 PM

Sunday, January 25, 2015 5:02:44 PM

Post# of 345969

Bio, you are very persuasive. I am upping my $50 today price to $50.01



Geo, progress is all I can ask for now, but now knowing about these HFT algo machines and BP M/A tactics I would strongly suggest to simply say "no, I will not accept $50" and even though you say would accept 1 cent more I would think your price would fly right past $50.01 and such as Peregrine in M/A tactics.

I hope Peregrine does not reveal their final bottom number for any possibly buyout, because those sitting on the other side also my fly right past what their number may be and it should change each day further the pipeline advances or any possibly other PS Targeting ventures appear.

Now Geo, you hopefully are (silently) willing to accept $55 but wait...

Imagine: Enhanced (with contrast) MRI's that are safer and more effective at detecting cancer and instead of having an enhanced MRI when absolutely necessary, what if some type of enhanced MRI was developed that could be used more proactively... vs last resort ? Even getting baseline results early in life and yearly. Hell, one backs up their computer but what about backing up their DNA?

Now Geo with each and every possible application, the price moves north and just as there are many that sat back and waited and hoped more shares would be freed up in the pool, now is the exact time where the flip side should sit back and wait and instead of freeing up shares for the opposition... freeze those shares in the pool. It will be funny though... siding and merging with the family on the next paradigm shift in another 100 years when one will need lots of money for those Synthetic DNA lines

Regarding MRI w/contrast, gadolinium-based contrast agents.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=109825321&txt2find=gadolinium|mri

Now Geo, you hopefully are (silently) willing to accept $60 but wait...there will be more


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News